A detailed history of New Millennium Group LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, New Millennium Group LLC holds 900 shares of CDNA stock, worth $19,278. This represents 0.02% of its overall portfolio holdings.

Number of Shares
900
Previous 900 -0.0%
Holding current value
$19,278
Previous $13,000 115.38%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$7.56 - $16.15 $6,804 - $14,534
900 New
900 $13,000
Q2 2022

Aug 18, 2022

BUY
$20.49 - $39.72 $18,441 - $35,748
900 New
900 $19,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track New Millennium Group LLC Portfolio

Follow New Millennium Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Millennium Group LLC with notifications on news.